MSTR
USDMicroStrategy Incorporated Common Stock Class A
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$255.010
Kõrge
$258.210
Madal
$245.870
Maht
16.92M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
70.9B
Tööstusharu
Software - Application
Riik
United States
Kauplemisstatistika
Keskmine maht
11.53M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Bitcoin retail investor at 'max desperation,' says Bitwise CIO, but crypto winter not coming
Bitcoin's fall below $100,000 sparks fears that a new crypto winter has begun, but Bitwise CIO Matt Hougan sees reasons why this selloff may not last long.
Strategy Announces Proposed Initial Public Offering of € Denominated STRE Stock
Strategy Inc (NASDAQ:STRF) today announced that, subject to market and other conditions, it intends to conduct an initial public offering registered under the Securities Act of 1933, as amended (the "Securities Act"),
Ether falls 7% following a multimillion dollar hack of a decentralized finance protocol
The Ethereum-linked token briefly fell below its critical $3,600 level as investors wrung their hands over several bearish events.
HC Wainwright & Co. Maintains Buy on Strategy, Lowers Price Target to $475
HC Wainwright & Co. analyst Mike Colonnese maintains Strategy with a Buy and lowers the price target from $521 to $475.
Canaccord Genuity Maintains Buy on Strategy, Raises Price Target to $474
Canaccord Genuity analyst Joseph Vafi maintains Strategy with a Buy and raises the price target from $464 to $474.
TD Cowen Maintains Buy on Strategy, Lowers Price Target to $535
TD Cowen analyst Lance Vitanza maintains Strategy with a Buy and lowers the price target from $620 to $535.
Cantor Fitzgerald Maintains Overweight on Strategy, Lowers Price Target to $560
Cantor Fitzgerald analyst Brett Knoblauch maintains Strategy with a Overweight and lowers the price target from $697 to $560.
Seotud aktsiad
YY
JOYY Inc. American Depositary Shares
IDCC
InterDigital Inc.
NCZ
Virtus Convertible & Income Fund II Common Shares of Beneficial Interest
ENZ
Enzo Biochem Inc. ($0.01 Par Value)
AEON
AEON Biopharma Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.